FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003754488> ?p ?o ?g. }

• W2003754488 endingPage "b5444" @default.
• W2003754488 startingPage "b5444" @default.
• W2003754488 abstract "To investigate potential determinants of severe hypoglycaemia, including baseline characteristics, in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial and the association of severe hypoglycaemia with levels of glycated haemoglobin (haemoglobin A(1C)) achieved during therapy.Post hoc epidemiological analysis of a double 2x2 factorial, randomised, controlled trial.Diabetes clinics, research clinics, and primary care clinics.10 209 of the 10 251 participants enrolled in the ACCORD study with type 2 diabetes, a haemoglobin A(1C) concentration of 7.5% or more during screening, and aged 40-79 years with established cardiovascular disease or 55-79 years with evidence of significant atherosclerosis, albuminuria, left ventricular hypertrophy, or two or more additional risk factors for cardiovascular disease (dyslipidaemia, hypertension, current smoker, or obese). Interventions Intensive (haemoglobin A(1C) <6.0%) or standard (haemoglobin A(1C) 7.0-7.9%) glucose control.Severe hypoglycaemia was defined as episodes of low blood glucose requiring the assistance of another person and documentation of either a plasma glucose less than 2.8 mmol/l (<50 mg/dl) or symptoms that promptly resolved with oral carbohydrate, intravenous glucose, or glucagon.The annual incidence of hypoglycaemia was 3.14% in the intensive treatment group and 1.03% in the standard glycaemia group. We found significantly increased risks for hypoglycaemia among women (P=0.0300), African-Americans (P<0.0001 compared with non-Hispanic whites), those with less than a high school education (P<0.0500 compared with college graduates), aged participants (P<0.0001 per 1 year increase), and those who used insulin at trial entry (P<0.0001). For every 1% unit decline in the haemoglobin A(1C) concentration from baseline to 4 month visit, there was a 28% (95% CI 19% to 37%) and 14% (4% to 23%) reduced risk of hypoglycaemia requiring medical assistance in the standard and intensive groups, respectively. In both treatment groups, the risk of hypoglycaemia requiring medical assistance increased with each 1% unit increment in the average updated haemoglobin A(1C) concentration (standard arm: hazard ratio 1.76, 95% CI 1.50 to 2.06; intensive arm: hazard ratio 1.15, 95% CI 1.02 to 1.21).A greater drop in haemoglobin A(1C) concentration from baseline to the 4 month visit was not associated with an increased risk for hypoglycaemia. Patients with poorer glycaemic control had a greater risk of hypoglycaemia, irrespective of treatment group. Identification of baseline subgroups with increased risk for severe hypoglycaemia can provide guidance to clinicians attempting to modify patient therapy on the basis of individual risk.ClinicalTrials.gov number NCT00000620." @default.
• W2003754488 created "2016-06-24" @default.
• W2003754488 creator A5003552905 @default.
• W2003754488 creator A5005503219 @default.
• W2003754488 creator A5008129967 @default.
• W2003754488 creator A5013984018 @default.
• W2003754488 creator A5020081483 @default.
• W2003754488 creator A5022083899 @default.
• W2003754488 creator A5024577116 @default.
• W2003754488 creator A5030985342 @default.
• W2003754488 creator A5034096266 @default.
• W2003754488 creator A5040717597 @default.
• W2003754488 creator A5041967659 @default.
• W2003754488 creator A5043355190 @default.
• W2003754488 creator A5044675147 @default.
• W2003754488 creator A5058310578 @default.
• W2003754488 creator A5070606330 @default.
• W2003754488 creator A5071915821 @default.
• W2003754488 creator A5083179774 @default.
• W2003754488 creator A5087059050 @default.
• W2003754488 creator A5089855065 @default.
• W2003754488 date "2010-01-08" @default.
• W2003754488 modified "2023-10-18" @default.
• W2003754488 title "The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study" @default.
• W2003754488 cites W1526927233 @default.
• W2003754488 cites W1598254642 @default.
• W2003754488 cites W172609984 @default.
• W2003754488 cites W1999804954 @default.
• W2003754488 cites W2012362230 @default.
• W2003754488 cites W2014554878 @default.
• W2003754488 cites W2058831278 @default.
• W2003754488 cites W2074308333 @default.
• W2003754488 cites W2076573528 @default.
• W2003754488 cites W2080065474 @default.
• W2003754488 cites W2085546759 @default.
• W2003754488 cites W2100442612 @default.
• W2003754488 cites W2102312517 @default.
• W2003754488 cites W2107648636 @default.
• W2003754488 cites W2124282046 @default.
• W2003754488 cites W2139912326 @default.
• W2003754488 cites W2150540429 @default.
• W2003754488 cites W2156888511 @default.
• W2003754488 cites W2158666727 @default.
• W2003754488 cites W2190748907 @default.
• W2003754488 cites W2275139239 @default.
• W2003754488 cites W2337454357 @default.
• W2003754488 cites W2735325912 @default.
• W2003754488 cites W2185276130 @default.
• W2003754488 doi "https://doi.org/10.1136/bmj.b5444" @default.
• W2003754488 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2803743" @default.
• W2003754488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20061360" @default.
• W2003754488 hasPublicationYear "2010" @default.
• W2003754488 type Work @default.
• W2003754488 sameAs 2003754488 @default.
• W2003754488 citedByCount "371" @default.
• W2003754488 countsByYear W20037544882012 @default.
• W2003754488 countsByYear W20037544882013 @default.
• W2003754488 countsByYear W20037544882014 @default.
• W2003754488 countsByYear W20037544882015 @default.
• W2003754488 countsByYear W20037544882016 @default.
• W2003754488 countsByYear W20037544882017 @default.
• W2003754488 countsByYear W20037544882018 @default.
• W2003754488 countsByYear W20037544882019 @default.
• W2003754488 countsByYear W20037544882020 @default.
• W2003754488 countsByYear W20037544882021 @default.
• W2003754488 countsByYear W20037544882022 @default.
• W2003754488 countsByYear W20037544882023 @default.
• W2003754488 crossrefType "journal-article" @default.
• W2003754488 hasAuthorship W2003754488A5003552905 @default.
• W2003754488 hasAuthorship W2003754488A5005503219 @default.
• W2003754488 hasAuthorship W2003754488A5008129967 @default.
• W2003754488 hasAuthorship W2003754488A5013984018 @default.
• W2003754488 hasAuthorship W2003754488A5020081483 @default.
• W2003754488 hasAuthorship W2003754488A5022083899 @default.
• W2003754488 hasAuthorship W2003754488A5024577116 @default.
• W2003754488 hasAuthorship W2003754488A5030985342 @default.
• W2003754488 hasAuthorship W2003754488A5034096266 @default.
• W2003754488 hasAuthorship W2003754488A5040717597 @default.
• W2003754488 hasAuthorship W2003754488A5041967659 @default.
• W2003754488 hasAuthorship W2003754488A5043355190 @default.
• W2003754488 hasAuthorship W2003754488A5044675147 @default.
• W2003754488 hasAuthorship W2003754488A5058310578 @default.
• W2003754488 hasAuthorship W2003754488A5070606330 @default.
• W2003754488 hasAuthorship W2003754488A5071915821 @default.
• W2003754488 hasAuthorship W2003754488A5083179774 @default.
• W2003754488 hasAuthorship W2003754488A5087059050 @default.
• W2003754488 hasAuthorship W2003754488A5089855065 @default.
• W2003754488 hasBestOaLocation W20037544881 @default.
• W2003754488 hasConcept C107130276 @default.
• W2003754488 hasConcept C120665830 @default.
• W2003754488 hasConcept C121332964 @default.
• W2003754488 hasConcept C126322002 @default.
• W2003754488 hasConcept C134018914 @default.
• W2003754488 hasConcept C2777180221 @default.
• W2003754488 hasConcept C2780668416 @default.
• W2003754488 hasConcept C2909938374 @default.
• W2003754488 hasConcept C555293320 @default.
• W2003754488 hasConcept C61511704 @default.

• next